Lars Nootbaar, Stats, Highlights, and His Role on the St. Louis Cardinals

Quick Answer

Lars Nootbaar is a 28-year-old outfielder who spent the first nine years of his professional career with the St. Louis Cardinals organization before being traded to the Arizona Diamondbacks at the 2026 MLB trade deadline.

After undergoing offseason surgery that delayed his 2026 debut, Nootbaar has been working to regain his offensive form while providing defensive versatility across all three outfield positions. He remains under team control through the 2027 season, making him a valuable asset for Arizona's playoff push.

Key Facts

• Nootbaar was drafted by the Cardinals in the eighth round of the 2018 MLB Draft and made his major league debut on June 22, 2021.
• He was traded from St. Louis to Arizona on August 4, 2026, with the Diamondbacks sending pitching prospects Daniel Eagen and Sandro Santana plus a player to be named later to the Cardinals.
• Nootbaar underwent surgery in the offseason and was expected to start the 2026 season on the injured list, delaying his debut with St. Louis.
• He is playing on a $5.25 million contract for 2026 and has one year of team control remaining beyond this season, with arbitration eligibility beginning in 2027 and free agency arriving no earlier than 2028.
• Through August 15, 2026, his MLB career batting line stands at .240/.340/.738 OPS with 61 home runs and 211 RBI across 1,872 at-bats.
• In 2025, his final full season with St. Louis, Nootbaar posted a .234/.325/.361 line with a 96 wRC+ — a notable drop after three consecutive seasons with a wRC+ of 114 or higher.
• Nootbaar's 2026 MLB stats show a .221/.332/.658 line with 3 home runs and 17 RBI in 190 at-bats, though his walk rate remains strong at 13.1%.
• He has played primarily left field (107 games in 2025) but has also seen time in center and right field, plus occasional DH duty.

The Journey from Eighth-Round Pick to Trade Asset

Lars Nootbaar's path to the major leagues was not a straight line. Selected in the eighth round of the 2018 draft out of the University of Southern California, he was not considered a can't-miss prospect.

His rise through the Cardinals system was steady rather than spectacular, built on a patient approach at the plate and the defensive versatility that would eventually define his big-league value. When Nootbaar debuted in June 2021, he arrived as a depth piece — a capable outfielder who could fill in across all three positions.

But his performance quickly outgrew that role. From 2022 through 2024, he posted wRC+ marks of 114 or higher in three consecutive seasons, establishing himself as an above-average offensive contributor who paired that production with dependable outfield defense.

His ability to take walks at a high clip made him a reliable on-base presence in the middle of a lineup that often needed exactly that. The 2025 season, however, represented a step backward.

His batting line slipped to .234/.325/.361 with a 96 wRC+ — a figure that sits slightly below league average. The decline was not catastrophic, but for a player whose value hinged on being a well-rounded contributor, the dip in production signaled that changes might be coming.

Injury issues compounded the problem. Nootbaar spent time on the injured list in 2025 with a left costochondral sprain, then underwent surgery for bilateral Haglund's deformity — a condition affecting the heel bone — in August of that year.

He was placed on the 60-day injured list on August 2, 2025, and the recovery from that procedure bled into the 2026 season. The Cardinals, meanwhile, were in the midst of a roster transition.

Reports from October 2025 indicated that Nootbaar might start the 2026 season on the injured list while still recovering, and the organization made clear it was open to reshaping the roster. By the time the 2026 trade deadline arrived, the path forward was obvious: Nootbaar's time in St.

Louis was coming to an end.

The August 2026 Trade Why It Happened and What Each Side Got

The trade that sent Nootbaar to Arizona was finalized minutes before the 2026 MLB trade deadline on August 4. The deal was straightforward: the Diamondbacks acquired Nootbaar, while the Cardinals received right-handed pitcher Daniel Eagen (ranked as Arizona's No.

5 prospect at the time) and left-handed pitcher Sandro Santana (Arizona's No. 26 prospect), along with a player to be named later.

For the Cardinals, the move was consistent with their stated direction. St.

Louis had been signaling for some time that it intended to get younger and restock its farm system. Moving a 28-year-old outfielder who had one year of team control remaining — and whose offensive production had declined in 2025 — for two pitching prospects fit squarely within that plan.

Eagen immediately became the Cardinals' No. 17 prospect, while Santana checked in at No.

22, giving St. Louis additional young arms to develop.

For Arizona, the motivation was more immediate. The Diamondbacks entered the deadline in the thick of the wild-card race, but their outfield had been decimated by injuries.

Jordan Lawlar and Lourdes Gurriel Jr. were both on the injured list, leaving the team scrambling for reliable outfield coverage.

Nootbaar's defensive flexibility — he can handle all three outfield spots — made him an ideal fit for a team needing to patch holes without sacrificing quality. The financial component of the deal was modest.

Nootbaar was playing on a $5.25 million contract for 2026, and with roughly two months remaining in the season, Arizona owed him approximately $1.5 million for the rest of the year, assuming no cash changed hands in the trade. From a baseball perspective, the trade was a calculated gamble for Arizona.

Nootbaar's 2026 numbers to that point — a .218 batting average with 3 home runs and a .648 OPS in 193 at-bats — were not inspiring. But his walk rate remained elite at 13.1%, right in line with his career mark, suggesting that his on-base skills had not eroded even as his overall production sagged.

For a team desperate for outfield help, that combination of defensive reliability and plate discipline was worth the modest cost.

What Nootbaar Brings to Arizona's Playoff Push

The Diamondbacks did not acquire Nootbaar expecting him to carry the offense. They acquired him to stabilize an outfield that had been stretched thin by injuries and to add a professional at-bat to a lineup that needed more of them.

Nootbaar's most consistent attribute throughout his career has been his ability to get on base. His career walk rate sits around 13%, a figure that places him among the more disciplined hitters in the league.

Even during his down 2025 season, when his batting average dipped to .234, his on-base percentage stayed at .325 — a number that remains useful, if not elite. In 2026, that pattern has continued: his .332 OBP is respectable even as his average has fallen to .221.

There is also the defensive component. In 2025, Nootbaar played 107 games in left field with a perfect 1.000 fielding percentage and a range factor of 1.54 per nine innings.

He also saw time in center field (12 games) and right field (23 games), demonstrating the kind of flexibility that managers value late in a season when lineups are constantly shifting. His overall outfield fielding percentage in 2025 was .996 across 227 total chances.

For Arizona manager Torey Lovullo, that versatility is a significant asset. The Diamondbacks can deploy Nootbaar in left field on days when Max Kepler needs a rest, slide him to center when matchups dictate, or use him in right field depending on the opposing lineup.

He is not a player who needs to be hidden defensively, which gives the coaching staff freedom in constructing the daily lineup. The early returns, however, have been mixed.

Nootbaar sat out of the lineup for Sunday's game against the Dodgers — the second time he was out of the series while the Diamondbacks went with Max Kepler in left field. He also missed Friday's game against Atlanta, sitting against a left-handed starter.

This platoon pattern suggests that Arizona views him as a complementary piece rather than an everyday player — someone to be deployed strategically rather than penciled in for 150 games. That is not necessarily a criticism.

Teams that make the playoffs often do so because role players understand their jobs and execute them. Nootbaar has spent his career being exactly that kind of player: a dependable contributor who does not need to be the star to make an impact.

The Recovery from Surgery and Its Impact on His 2026 Season

Nootbaar's 2026 season has been defined by the surgery he underwent in the offseason. The procedure — a bilateral Haglund's deformity excision — addressed a condition affecting both heels that had caused persistent pain and limited his mobility.

The surgery took place in August 2025, and the recovery timeline pushed his 2026 debut into question. Reports from October 2025 indicated that Nootbaar was expected to start the 2026 season on the injured list.

That projection proved accurate. He did not join the Cardinals at the start of the season, instead beginning the year on the shelf while completing his rehabilitation.

When Nootbaar finally did return, the layoff showed. His 2026 numbers — a .221 batting average with a .658 OPS — are the worst of his career.

The power, which had already declined in 2025, has not returned; he has managed just 3 home runs in 190 at-bats. His stolen base total is similarly modest at 2, suggesting that the heel surgery may still be limiting his explosiveness on the bases.

The rehabilitation process itself was extensive. Before his return, Nootbaar spent time on a rehab assignment with the Springfield Cardinals, the team's Double-A affiliate.

He played in nine games there, working his way back into game shape before rejoining the major league roster. The process was deliberate, reflecting both the severity of the surgery and the Cardinals' desire to avoid rushing him back.

The 2025 season had already been disrupted by injuries before the heel surgery. Nootbaar spent time on the 10-day injured list in July 2025 with a left costochondral sprain — an injury to the cartilage connecting the ribs to the breastbone — before being activated on August 2.

He was immediately placed on the 60-day injured list the same day to undergo the heel procedure, ending his season. That lost time matters.

For a player whose game is built on timing and rhythm, missing extended stretches in consecutive seasons can have a compounding effect. Nootbaar's 2025 production was already below his established baseline, and the 2026 season has not provided the bounce-back that a fully healthy year might have offered.

The question now is whether he can find his form before the season ends. Arizona did not acquire him for what he had done in 2026; they acquired him for what he could do in the final two months.

If his walk rate holds and his defense remains steady, he can be a useful piece even without the power numbers returning.

What the Future Holds for Nootbaar and the Diamondbacks

Nootbaar's contract situation makes him an interesting piece for Arizona beyond the 2026 season. He is signed through the end of the year at $5.25 million, with one additional year of team control remaining.

He becomes arbitration-eligible in 2027, which means the Diamondbacks can retain him at a reasonable cost for another season before he reaches free agency no earlier than 2028. That timeline aligns with Arizona's competitive window.

The Diamondbacks are in a wild-card race in 2026, and their outfield injuries have exposed a need for reliable, versatile players. Nootbaar fits that profile, and having him under control for 2027 gives the front office flexibility in planning the offseason roster.

For Nootbaar personally, the trade represents something of a fresh start. His final seasons in St.

Louis were defined by injuries and declining production. The Cardinals were moving in a different direction, and the trade gave both sides clarity.

In Arizona, he has the opportunity to reset his narrative — to show that the player who posted three consecutive seasons with a wRC+ of 114 or higher still exists beneath the injuries and the rust. The early signs are not overwhelming.

His playing time has been inconsistent, with platoon situations keeping him out of the lineup against left-handed pitching. But the underlying skills remain.

A 13.1% walk rate does not disappear overnight. Defensive versatility does not erode with age at 28.

The question is whether the offensive timing will return. The 2026 season is not over.

The Diamondbacks are playing meaningful games in August and September, and Nootbaar will have opportunities to contribute. Whether those opportunities turn into production will determine not just his immediate impact but also how Arizona views him heading into the offseason.

For now, the trade looks like a reasonable wager for both sides. The Cardinals added two pitching prospects to a farm system in need of arms.

The Diamondbacks added a veteran outfielder with playoff experience and a proven track record of getting on base. Neither side gave up a piece that would be considered untouchable.

The real evaluation will come over the next two months. If Nootbaar helps Arizona reach the postseason, the trade will be judged as a success regardless of his individual numbers.

If the Diamondbacks fall short, the deal becomes another footnote in a season of what-ifs. Either way, Nootbaar's career has taken an unexpected turn.

From an eighth-round pick in 2018 to a nine-year member of the Cardinals organization to a trade-deadline acquisition for a contender — it has been a journey defined by adaptability. That trait will serve him well as he finishes out the 2026 season and looks toward 2027.

Frequently Asked Questions

Why did the Cardinals trade Lars Nootbaar?

The Cardinals traded Nootbaar to Arizona at the 2026 deadline as part of a broader roster transition. St.

Louis received two pitching prospects — Daniel Eagen and Sandro Santana — plus a player to be named later. Nootbaar's offensive production had declined in 2025, and with only one year of team control remaining beyond 2026, the Cardinals chose to move him for younger assets rather than retain him through his arbitration years.

What injury did Lars Nootbaar have, and how did it affect his 2026 season?

Nootbaar underwent surgery for bilateral Haglund's deformity — a condition affecting both heels — in August 2025. The procedure ended his 2025 season and pushed his 2026 debut into question.

He was expected to start the 2026 season on the injured list, and his recovery required a rehab assignment with the Springfield Cardinals before he rejoined the major league roster.

How much money will Nootbaar earn with the Diamondbacks in 2026?

Nootbaar is playing on a $5.25 million contract for 2026. When the Diamondbacks acquired him at the trade deadline, they owed him approximately $1.5 million for the remainder of the season, assuming no cash was exchanged in the deal.

What are Nootbaar's career statistics through the 2026 season?

Through August 15, 2026, Nootbaar has a career batting average of .240 with 61 home runs, 211 RBI, and 30 stolen bases. His career OPS is .738.

In 2026 specifically, he has hit .221 with 3 home runs and 17 RBI in 190 at-bats.

Is Nootbaar under contract with Arizona beyond 2026?

Yes. Nootbaar has one year of team control remaining beyond the 2026 season.

He becomes arbitration-eligible in 2027 and is not scheduled to reach free agency until 2028 at the earliest.

Reference Notes

Information in this article is based on publicly available sources. Some details may change over time.

Verify with official sources before acting.